1: \begin{abstract}

2: Learning an individualized dose rule in personalized medicine is a challenging statistical problem. Existing methods for estimating the optimal individualized dose rule often suffer from the curse of dimensionality, especially when the dose rule is learned nonparametrically using machine learning approaches. To tackle this problem, we propose a dimension reduction framework that effectively reduces the estimation of dose rule in a lower-dimensional subspace of the covariates, leading to a more parsimonious model. To achieve this, the proposed methods exploit that the subspace is spanned by a few linear combinations of the covariates, which can be estimated efficiently by using an orthogonality constrained optimization approach. Using this framework, we proposed a direct estimation of the value function under any given suggested dose rule with dimension reduction. This does not require an inverse probability of the propensity score, which distinguishes us from the popular outcome weighted learning framework. We further propose two approaches: a direct learning approach that yields the dose rule as commonly desired in personalized medicine, and a pseudo-direct learning approach that focuses more on estimating the dimensionality-reduced subspace. Under mild regularity assumptions, the asymptotical normality of the proposed subspace estimators is established respectively. The consistency and convergence rate for the estimated optimal dose rule are also derived. For both approaches, we formulate an effectively numerical optimization problem as solving solutions on the Stiefel manifold. The performance of the proposed approaches is evaluated through simulation studies and a warfarin pharmacogenetic dataset.

3: \end{abstract}

4: